In agreement with the proposed role of insulin signaling in cognition, intranasal administration of insulin has been reported to improve memory in healthy humans (Benedict et al., 2004, 2007) and in individuals with mild cognitive impairment and AD (Reger et al., 2008a, b; Craft et al., 2012). This evidence concerns the gene INS and Alzheimer disease.